5/16
02:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
5/16
02:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
5/16
01:58 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
5/16
01:58 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
4/25
08:01 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
3/27
07:44 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
3/27
07:44 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
3/26
02:07 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
3/26
02:07 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
3/26
01:38 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
3/26
12:26 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
3/18
03:04 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
3/18
02:58 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $120.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $120.00 price target on the stock.
3/18
02:55 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $80.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $80.00 price target on the stock.
3/18
02:55 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $80.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $80.00 price target on the stock.
3/15
01:23 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
3/15
12:33 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
3/15
11:16 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
3/7
06:36 am
vktx
Rating for VKTX
High
Report
Rating for VKTX
3/7
06:36 am
vktx
Rating for VKTX
High
Report
Rating for VKTX